Byrsonima fagifolia: An integrative study to validate the gastroprotective, healing, antidiarrheal, antimicrobial and mutagenic action

Journal of Ethnopharmacology

Volumn 120, Issue 2, 2008, Pages 149-160

  Lima, Zeila Pinheiro ^a   dos Santos, Raquel de Cássia ^a   Torres, Talita Uliana ^a   Sannomiya, Miriam ^a   Rodrigues, Clenilson Martins ^a   dos Santos, Lourdes Campaner ^a   Pellizzon, Cláudia Helena ^a   Rocha, Lúcia Regina Machado ^a   Vilegas, Wagner ^a   Souza Brito, Alba Regina Monteiro ^b   Cardoso, Cássia Regina Primila ^a   Varanda, Eliana Aparecida ^a   de Moraes, Helen Pimenta ^a   Bauab, Taís Maria ^a   Carli, Camila ^a   Carlos, Iracilda Zeppone ^a   Hiruma Lima, Clélia Akiko ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Antidiarrheal action; Byrsonima fagifolia; Healing effect; Malpighiaceae; Mutagenicity

Indexed keywords

ACETIC ACID ETHYL ESTER; ALCOHOL; ANTIDIARRHEAL AGENT; BYRSONIMA FAGIFOLIA EXTRACT; CARBENOXOLONE; CASTOR OIL; CHLORIDE; CIMETIDINE; GASTROINTESTINAL AGENT; LANSOPRAZOLE; METHANOL; PHENOL DERIVATIVE; PLANT EXTRACT; SCAVENGER; UNCLASSIFIED DRUG;

AMES TEST; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BRAZIL; BYRSONIMA FAGIFOLIA; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG MECHANISM; DRUG SAFETY; ESCHERICHIA COLI; ETHNOPHARMACOLOGY; GASTROINTESTINAL DISEASE; HEALING; HELICOBACTER PYLORI; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; INTESTINE MOTILITY; MALE; MALPIGHIACEAE; MEDICINAL PLANT; MOUSE; MUTAGENIC ACTIVITY; NONHUMAN; PERITONEUM MACROPHAGE; PHYTOCHEMISTRY; PLANT LEAF; RAT; RODENT; STAPHYLOCOCCUS AUREUS; STOMACH MUCUS; STOMACH ULCER;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; ANTIDIARRHEALS; ANTIOXIDANTS; BRAZIL; DISEASE MODELS, ANIMAL; FREE RADICAL SCAVENGERS; IMMUNOLOGIC FACTORS; MACROPHAGES, PERITONEAL; MALE; MALPIGHIACEAE; MEDICINE, TRADITIONAL; MICE; MUTAGENICITY TESTS; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, WISTAR; STOMACH ULCER; TOXICITY TESTS;

BYRSONIMA; ESCHERICHIA COLI; HELICOBACTER PYLORI; MALPIGHIACEAE; MURINAE; RODENTIA; STAPHYLOCOCCUS AUREUS;

EID: 55349107217     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.07.047     Document Type: Article

References (59)

1. Agrawal P.K. Carbon 13 NMR of Flavonoids (1989), Elsevier, Amsterdam p. 564
2. Amarquaye A., Che C.T., Bejar E., Malone M.H., and Fong H.H. A new glycolipid from Byrsonima crassifolia. Planta Medica 60 (1994) 85-86
3. Antonio M.A., and Souza Brito A.R. Oral anti-inflammatory and anti-ulcerogenic activities of a hydroalcoholic extract and partitioned fractions of Turnera ulmifolia (Turneraceae). Journal of Ethnopharmacology 61 (1998) 15-28
4. Arrieta J., Benitez J., Flores E., Castillo C., and Navarrete A. Purification of gastroprotective triterpenoids from the stem bark of Amphipterygium adstringens; role of prostaglandins, sulphydryls, nitric oxide and capsaicin-sensitive neurons. Planta Medica 69 (2003) 905-909
5. Azuma K., Ippoushi K., Nakayama M., Ito H., Higashio H., and Terao J. Absorption of chlorogenic acid and caffeic acid in rats after oral administration. Journal of Agriculture Food Chemistry 48 (2000) 5496-5500
6. Behmer, O.A., Tolosa, E.M.C., Freitas Neto, A.G., 1976. Manual de técnicas para histologia normal e patológica. EDART-Editora da Universidade de São Paulo, p. 241.
7. Bergonzelli G.E., Donnicola D., Porta N., and Corthésy-Theulaz I.E. Essential oils as components of a diet-based approach to management of Helicobacter infection. Antimicrobial Agents Chemotherapy 47 (2003) 3240-3246
8. Bernstein L., Kaldor J., McCann J., and Pike M.C. An empirical approach to the statistical analysis of mutagenesis data from the Salmonella test. Mutation Research 97 (1982) 267-281
9. Binutu O.A., and Cordell G.A. Gallic acid derivatives from Mezoneuron benthamianum leaves. Pharmacological Biology 38 (2000) 284-286
10. Carvajal A., Arias L.H., Vega E., Sánchez J.A., Rodríguez I.M., Ortega P.G., and Del Pozo J.G. Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization study. European Journal Clinical Pharmacology 60 (2004) 439-444
11. Crocci T., Emonds-ALT X., and Manara L. SR 48968 selectively prevents faecal excretion following activation of tachykinin NK2 receptors in rats. Journal of Pharmacy and Pharmacology 46 (1994) 383-385
12. Deshpande S.S., Shah G.B., and Parmar N.S. Antiulcer activity of Tephosia purpurea in rats. Indian Journal Pharmacology 35 (2003) 168-172
13. Finn P.E., Purnell P., and Pilkington G.J. Effect of histamine and the H2 antagonist cimetidine on the growth and migration of human neoplastic glia. Neuropathology and Applied Neurobiology 22 (1996) 559
14. Galati E.M., Mondello M.R., Giuffrida D., Dugo G., Miceli N., Pergolizzi S., and Taviano M.F. Chemical characterization and biological effects of Sicilian Opuntia ficus indica (L.) Mill. Fruit juice: antioxidant and antiulcerogenic activity. Journal of Agriculture Food Chemistry 51 (2003) 4903-4908
15. 15N] nitrate in biological fluids. Analytical Biochemistry 126 (1982) 131-138
16. Grob N.G. Peptic ulcer in twenty-century of America. New Jersey Medicine 101 (2004) 19-28
17. Gyires K. Gastric mucosal protection: from prostaglandins to gene-therapy. Current Medicinal Chemistry 12 (2005) 203-215
18. Harborne J.B. The Flavonoids: Advances in Research Since 1986 (1996), Chapman & Hall, New York p. 676
19. Ishihara M., and Ito M. Influence of aging on gastric ulcer healing activities of cimetidine and omeprazole. European Journal of Pharmacology 31 (2002) 209-215
20. Jung H.K., Lee K.E., Chu S.H., and Yi S.Y. Reactive oxygen species activity, mucosal lipoperoxidation and glutathione in Helicobacter pylori-infected gastric mucosa. Journal of Gastroenterology and Hepatology 16 (2001) 1336-1340
21. Kimura M., Goto S., Lhara Y., Wada A., Yahiro K., Niidome T., Aoyagi H., Hirayama T., and Kondo T. Impairment of glutathione metabolism in human gastric epithelial cells treated with vacuolating cytotoxin from Helicobacter pylori. Microbial Pathogenesis 31 (2001) 29-36
22. Kosek M., Bern C., and Guerrant R.L. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bulletin World Health Organization 81 (2003) 197-204
23. Kwiicien S., Brzowski T., and Konturek S.J. Effects of reactive oxygen species action on gastric mucosa in various models of mucosal injury. Journal of Physiology and Pharmacology 53 (2002) 39-50
24. Levine R.J. A method for rapid production of stress ulcers in rats. In: Pfeiffer C.J. (Ed). Peptic Ulcer (1971), Munksgaard, Copenhagen 92-97
25. Loibl S., Bratengeier J., Farines V., Von Minckwitz G., Spankuch B., Shini-Kerth V., Nepveu F., Strebhardt K., and Kaufmann M. Investigations on the inducible and endothelial nitric oxide synthases in human breast cancer cell line MCF-7-estrogen has an influence on e-NOS, but not on i-NOS. Pathology-Research and Practice 202 (2006) 1-7
26. Lopes F.C.M., Calvo T.R., Vilegas W., and Carlos I.Z. Inhibition of hydrogen peroxide, nitric oxide and TNF-α production in peritoneal macrophages by ethyl acetate fraction from Alchornea glandulosa. Biological and Pharmaceutical Bulletin 28 (2005) 1726-1730
27. Maron D.M., and Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutation Research 113 (1983) 173-215
28. Marona H.R.N., and Lucchesi M.B.B. Protocol to refine intestinal motility test in mice. Royal Society of Medicine Press 38 (2004) 257-260
29. Maton P.N. Prevention of stress-related mucosal bleeding with proton-pump inhibitors. Alimentary Pharmacology and Therapeutics 22 (2005) 45-52
30. Mizui T., and Doteuchi M. Effect of polyamines on acidified ethanol-induced gastric lesions in rats. Japanese Journal of Pharmacology 33 (1983) 934-945
31. Morimoto Y., Shimohara K., Oshima S., and Sukamoto T. Effects of the new anti-ulcer agent KB-5492 on experimental gastric mucosal lesions and gastric mucosal defensive factors, as compared to those of teprenone and cimetidine. Japanese Journal and Pharmacology 57 (1991) 495-505
32. Mortelmans K., and Zeiger E. The Ames Salmonella/microsome mutagenicity assay. Mutation Research 455 (2000) 29-60
33. Nanji A.A., and Tahan S.R. Association between endothelial cell proliferation and patologic changes in experimental alcoholic liver disease. Toxicological and Applied Pharmacology 140 (1996) 101-107
34. Okabe S., and Amagase K. An overview of acetic acid ulcer models-the history and state of the art of peptic ulcer research. Biological and Pharmaceutical Bulletin 28 (2005) 1321-1341
35. Okamoto R., and Watanabe M. Molecular and clinical basis for the regeneration of human gastrointestinal epithelia. Journal of Gastroenterology 39 (2004) 1-6
36. Olfert E.D., Cross B.M., and McWilliam A.A. Guide to the Care and Use of Experimental Animals (1993), Canadian Council on Animal Care Co., Ontario p. 213
37. Palombo E.A. Phytochemicals from traditional medicinal plants used in the treatment of diarrhoea: modes of action and effects on intestinal function. Phytotherapy Research 20 (2006) 717-724
38. Peskar B.M., and Maricic N. Role of prostaglandins in gastroprotection. Digestion Disease Sciences 43 (1998) 23S-29S
39. Potterat O. Antioxidants and free radical scavengers of natural origin. Current Organic Chemistry 1 (1997) 415-440
40. Puscas I., Puscas C., Coltau M., Pasça R., Torres J., Márquez M., Herrero E., Fillat O., and Ortiz J.A. Comparative study of the safety and efficacy of ebrotidine versus ranitidine and placebo in the prevention of piroxicam-induced gastroduodenal lesions. Arzneimittelforschung 47 (1997) 568-572
41. Rastogi L., Patnaik G.K., and Dikshit M. Free radicals and antioxidant status following pylorus ligation induced gastric mucosal injury in rats. Pharmacological Research 38 (1998) 125-132
42. Repetto M.G., and Llesuy S.F. Antioxidant properties of natural compounds used in popular medicine for gastric ulcers. Brazilian Journal of Medical and Biological Research 35 (2002) 523-534
43. Ribeiro A.Q., Sevalho G., and César C.C. The use of nonsteroidal anti-inflammatory drugs and the occurrence of gastric lesions among patients undergoing upper endoscopy in a university hospital in Brazil. Clinics 61 (2006) 409-416
44. Salvat A., Antonacci L., Fortunato R.H., Suarez E.Y., and Godoy H.M. Antimicrobial activity in methanolic extracts of several plant species from northern Argentina. Phytomedicine 11 (2004) 230-234
45. Sannomiya M., Cardoso C.R., Figueiredo M.E., Rodrigues C.M., dos Santos L.C., dos Santos F.V., Serpeloni J.M., Cólus I.M., Vilegas W., and Varanda E.A. Mutagenic evaluation and chemical investigation of Byrsonima intermedia A. Juss. leaf extracts. Journal of Ethnopharmacology 112 (2007) 319-326
46. Sannomiya M., Fonseca V.B., da Silva M.A., Rocha L.R., Dos Santos L.C., Hiruma-Lima C.A., Souza Brito A.R., and Vilegas W. Flavonoids and antiulcerogenic activity from Byrsonima crassa leaves extracts. Journal of Ethnopharmacology 97 (2005) 1-6
47. Santos F.V., Colus I.M.S., Silva M.A., Vilegas W., and Varanda E.A. Assessment of DNA damage induced by extracts and fractions of Strychnos pseudoquina, a Brazilian medicinal plant with antiulcerogenic activity. Food and Chemical Toxicology 44 (2006) 1585-1589
48. Schmeda-Hirschmann G., and Yesilada E. Traditional medicine and gastroprotective crude drugs. Journal of Ethnopharmacology 100 (2005) 61-66
49. Shah A.M. Divergent roles of endothelial nitric oxide synthase in cardiac hypertrophy and chamber dilatation?. Cardiovascascular Research 66 (2005) 421-422
50. Silva E.M., Hiruma-Lima C.A., and Lolis S.F. Levantamento etnofarmacológico no municipio de Porto Nacional, Tocantins. XVI Simpósio de Plantas Medicinais do Brasil. Recife, PE, Brazil. Conference Proceeding (2000) 106
51. Szabo S., Trier J.S., and Frank P.W. Sulfhydryl compounds may mediate gastric protection. Science 214 (1981) 200-202
52. Szelenyi I., and Thiemer K. Distention ulcer as a model for testing of drugs for ulcerogenic side effects. Archieves of Toxicology 41 (1978) 99-105
53. Takagi K., Okabe S., and Saziki R. A new method for the production of chronic gastric ulcer in rats and the effect of several drugs on its healing. Japanese Journal of Pharmacology 19 (1969) 418-426
54. Tamir S., and Tannenbaum S.R. The role of nitric oxide (NO) in the carcinogenic process. Biochimica et Biophysica Acta 1288 (1996) 31-36
55. Tarnawski A., Szabo I.L., Husain S.S., and Soreghan B. Regeneration of gastric mucosa during ulcer healing is triggered by growth factors and signal transduction pathways. Journal of Physiology Paris 95 (2001) 337-344
56. Vacca L.L. Laboratory Manual of Histochemistry (1985), Raven Press, New York p. 578
57. Wagner H., Bladt H., and Zgainski E.M. Plant Drug Analysis (1984), Springer, Berlin p. 320
58. Wallace J.L., and Granger D.N. The cellular and molecular basis of gastric mucosal defense. Federation of American Societies for Experimental Biology Journal 10 (1996) 731-740
59. Wong W.M., and Wright N.A. Cell proliferation in gastrointestinal mucosa. Journal of Clinical Pathology (1999) 321-333